rs773801386
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_181426.2(CCDC39):c.830_831delCA(p.Thr277fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000105 in 1,604,204 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 0 hom. )
Consequence
CCDC39
NM_181426.2 frameshift
NM_181426.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.36
Genes affected
CCDC39 (HGNC:25244): (coiled-coil domain 39 molecular ruler complex subunit) The protein encoded by this gene is involved in the motility of cilia and flagella. The encoded protein is essential for the assembly of dynein regulatory and inner dynein arm complexes, which regulate ciliary beat. Defects in this gene are a cause of primary ciliary dyskinesia type 14 (CILD14). [provided by RefSeq, Jul 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-180654860-CTG-C is Pathogenic according to our data. Variant chr3-180654860-CTG-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 242176.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-180654860-CTG-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152080Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
152080
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000112 AC: 163AN: 1452124Hom.: 0 AF XY: 0.0000928 AC XY: 67AN XY: 721748
GnomAD4 exome
AF:
AC:
163
AN:
1452124
Hom.:
AF XY:
AC XY:
67
AN XY:
721748
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74300
GnomAD4 genome
AF:
AC:
6
AN:
152080
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74300
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 30, 2023 | This sequence change creates a premature translational stop signal (p.Thr277Argfs*3) in the CCDC39 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CCDC39 are known to be pathogenic (PMID: 21131972, 23255504). This variant is present in population databases (rs773801386, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with primary ciliary dyskinesia (PMID: 2325550, 23891469). ClinVar contains an entry for this variant (Variation ID: 242176). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 24, 2023 | The c.830_831delCA pathogenic mutation, located in coding exon 7 of the CCDC39 gene, results from a deletion of two nucleotides at nucleotide positions 830 to 831, causing a translational frameshift with a predicted alternate stop codon (p.T277Rfs*3). This mutation has been identified in the homozygous and compound heterozygous state in several individuals with primary ciliary dyskinesia (Zariwala MA et al. Am J Hum Genet, 2013 Aug;93:336-45; Antony D et al. Hum Mutat, 2013 Mar;34:462-72; Davis SD et al. Am J Respir Crit Care Med, 2019 Jan;199:190-198). In addition to the clinical data presented in the literature, yhis alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Likely pathogenic, no assertion criteria provided | literature only | Yale Center for Mendelian Genomics, Yale University | Aug 01, 2018 | - - |
Primary ciliary dyskinesia 14 Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 26, 2018 | The CCDC39 c.830_831delCA (p.Thr277ArgfsTer3) variant results in a frameshift and is predicted to result in premature termination of the protein. The p.Thr277ArgfsTer3 variant has been reported in three studies and was found in a total of six individuals with primary ciliary dyskinesia, including in two in a homozygous state and in four in a compound heterozygous state, although three of the compound heterozygous probands were members of the same family (Antony et al. 2013; Zariwala et al. 2013; Kim et al. 2014). The homozygous individual reported by Antony et al. (2013) also had three unaffected family members who carried the variant in a heterozygous state. Control data are unavailable for this variant. The highest reported frequency for the variant in the Exome Sequencing Project is 0.00828 in the African American population. However, this frequency is orders of magnitude higher than the highest frequency reported in the Exome Aggregation Consortium, where the p.Thr277ArgfsTer3 variant is found at a frequency of 0.00008 in the European (non-Finnish population). Due to the difficulty in calling indels, the frequency of this variant in the Exome Sequencing Project, which is inconsistent with the disease prevalence, is not considered reliable. Based on the evidence, including the potential impact of truncating frameshift variants, the p.Thr277ArgfsTer3 variant is considered to be likely pathogenic for primary ciliary dyskinesia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 25, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 22, 2024 | Variant summary: CCDC39 c.830_831delCA (p.Thr277ArgfsX3) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position. c.830_831delCA has been reported in the literature in at-least one individual affected with Primary ciliary dyskinesia (example, Kim_2014). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 24498942). ClinVar contains an entry for this variant (Variation ID: 242176). Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 17, 2024 | Observed with a pathogenic variant on the opposite allele (in trans) as well as in the homozygous state in association with primary ciliary dyskinesia in several patients in the published literature (PMID: 23891469, 23255504, 30067075); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 24498942, 31589614, 23255504, 31879361, 30067075, 35942088, 36809189, 36593399, 23891469) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at